MYELODYSPLASTIC SYNDROMES, HIGH RISK

Clinical trials for MYELODYSPLASTIC SYNDROMES, HIGH RISK explained in plain language.

Never miss a new study

Get alerted when new MYELODYSPLASTIC SYNDROMES, HIGH RISK trials appear

Sign up with your email to follow new studies for MYELODYSPLASTIC SYNDROMES, HIGH RISK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Lab-Grown cord blood offers new hope for patients without donors

Disease control Recruiting now

This study is testing a new method to improve stem cell transplants for adults with high-risk blood cancers like leukemia who cannot find a matching donor. Doctors take stem cells from donated umbilical cord blood and grow them in the lab using a special molecule called UM171, ai…

Matched conditions: MYELODYSPLASTIC SYNDROMES, HIGH RISK

Phase: PHASE1, PHASE2 • Sponsor: Ciusss de L'Est de l'Île de Montréal • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

MYELODYSPLASTIC SYNDROMES, HIGH RISK

Get alerted when new MYELODYSPLASTIC SYNDROMES, HIGH RISK trials appear

Lab-Grown cord blood offers new hope for patients without donors